Preclinical News and Research

RSS
Researchers identify small-molecule drug candidates for many metabolic conditions

Researchers identify small-molecule drug candidates for many metabolic conditions

Positive results from DARA's DB959 Phase 1b study on type 2 diabetes

Positive results from DARA's DB959 Phase 1b study on type 2 diabetes

Rigel reports net loss of $17.9 million for third quarter 2011

Rigel reports net loss of $17.9 million for third quarter 2011

UL, IU and UMMS to implement Center for Excellence in Health and Life Sciences

UL, IU and UMMS to implement Center for Excellence in Health and Life Sciences

iBio receives U.S. patent entitled 'System for Expression of Genes in Plants'

iBio receives U.S. patent entitled 'System for Expression of Genes in Plants'

European Congress on Osteoporosis & Osteoarthritis to be held March 21-24

European Congress on Osteoporosis & Osteoarthritis to be held March 21-24

NCI awards ImaginAb $2.3M grant to develop PET diagnostic imaging agents

NCI awards ImaginAb $2.3M grant to develop PET diagnostic imaging agents

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

Pacira's third quarter total revenues decrease to $4.0 million

Pacira's third quarter total revenues decrease to $4.0 million

Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting

Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting

BerGenBio commences preclinical development of BGB324 anti-cancer drug

BerGenBio commences preclinical development of BGB324 anti-cancer drug

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

ZIOPHARM reports promising preclinical data with palifosfamide in pediatric sarcoma model

ZIOPHARM reports promising preclinical data with palifosfamide in pediatric sarcoma model

New drug could combat cardiovascular disease

New drug could combat cardiovascular disease

Biogen Idec enters global collaboration for oral Syk inhibitor program with Portola

Biogen Idec enters global collaboration for oral Syk inhibitor program with Portola

NCI awards UAB $2.3M brain-tumor SPORE grant

NCI awards UAB $2.3M brain-tumor SPORE grant

Study: pGJA-P/VAX vaccine shows promise against dental caries

Study: pGJA-P/VAX vaccine shows promise against dental caries

Surgeons freeze organoid units and regenerate TESI for short bowel syndrome

Surgeons freeze organoid units and regenerate TESI for short bowel syndrome

Biogen’s Multiple Sclerosis pill succeeds at a late phase clinical trial

Biogen’s Multiple Sclerosis pill succeeds at a late phase clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.